Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2022 Earnings Conference Call November 2, 2022 8:00 AM ET

Company Participants

Bennett Watson - Westwicke, Investor Relations

Dan Barber - Chief Executive Officer

Ernie Toth - Senior Vice President, Chief Financial Officer

Ken Truitt - Chief Medical Officer

Ken Marshall - Chief Commercial Officer

Steve Wargacki - Head of R&D

Conference Call Participants

Dennis Resnick - BMO

Jason Butler - JMP Securities

Francois Brisebois - Oppenheimer

Thomas Flaten - Lake Street Capital Markets

Andreas Argyrides - Wedbush

Laura Searle - Alliance

Operator

Good morning, and welcome to the Aquestive Therapeutics Third Quarter 2022 Conference Call. At this time, all participants are in a listen only-mode. After the speakers' remarks, there will be a question-and-answer session. Instructions will be given at that time. As a reminder, this call will be recorded.

I would now like to introduce your host for today’s conference call, Bennett Watson of Westwicke, Investor Relations. You may begin.

Bennett Watson

Thank you, operator. Good morning, and welcome to today's call. On today's call, I am joined by Dan Barber, Chief Executive Officer; and Ernie Toth, Chief Financial Officer, who are going to provide an overview of recent business developments and performance for the third quarter 2022, followed by a Q&A session. During the Q&A session, the team will be joined by Dr. Steve Wargacki, Vice President of R&D; and Ken Truitt, Chief Medical Officer; and Ken Marshall, Chief Commercial Officer.

As a reminder, the company's remarks today correspond with their earnings release that was issued after market close yesterday. In addition, a recording of today's call will be made available on Aquestive's website within the Investors section shortly following the conclusion of this call.

To remind you, the Aquestive team will be discussing some non-GAAP financial measures this morning as part of its review of third quarter 2022 results. A description of these measures, along with a reconciliation to GAAP, can be found in the earnings release issued yesterday, which is posted on the Investors section of Aquestive's website.

During the call, the company will be making forward-looking statements. We remind you of the company's safe harbor language as outlined in yesterday's earnings release, as well as the risks and uncertainties affecting the company as described in the Risk Factors section and in other sections included in our annual report on Form 10-K filed with the Securities and Exchange Commission on March 8, 2022, and in our quarterly reports on Form 10-Q and current reports on Form 8-K with the SEC.